BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and...
AQEMIA continues to grow rapidly in its effort to discover new drugs with their generative-AI fueled by deep physics. After raising €30M last year, the...
This launch aims to elevate chest abnormality detection in Samsung's premium X-ray devices and help clinicians provide a more efficient care path for patients
Boston Imaging,...
Genialis, the RNA-biomarker company, and Debiopharm, a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases,...
Merck to evaluate Variational AI’s Enki™ generative AI platform to design novel and selective small molecules
Variational AI, developer of the Enki™ generative artificial intelligence...
The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws
Researchers at City...
A leading South Korean company providing a total solution for PCR molecular diagnostics, announced its selection of Microsoft as a technology partner for its...
Bionano Genomics, Inc. announced the full commercial release of the Stratys™ system, the Company’s system for high throughput optical genome mapping (OGM).
As part of...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Dr. Joerg Moeller as Chief Executive Officer and...
LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments
Thirona, a global company...